Lola joined 4P-Pharma in 2021 as Junior Project Manager to support and implement the development of our projects, especially 4P020, our drug candidate for dAMD and Stargardt disease.

Lola is also actively involved in the communication strategy and operation of 4P-Pharma.

Lola holds a PhD in Cell and Molecular Biology from Université Paris Est (Créteil, France) on a project in collaboration with the Institute of Human Genetics of Montpellier (France).